Evidence map›Paper›PMID 36895113›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

The Combination of

Sanyun Wu, Ping Luo, Tuerxunayi Rouzi, Yalan Yu, Bei Xiong, Yingying Wang, Xuelan Zuo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sanyun WuDepartment of Hematology, 89674Zhongnan Hospital of Wuhan University, Wuhan, China.
Ping LuoDepartment of Hematology, 89674Zhongnan Hospital of Wuhan University, Wuhan, China.
Tuerxunayi RouziDepartment of Hematology, 89674Zhongnan Hospital of Wuhan University, Wuhan, China.
Yalan YuDepartment of Hematology, 89674Zhongnan Hospital of Wuhan University, Wuhan, China.
Bei XiongDepartment of Hematology, 89674Zhongnan Hospital of Wuhan University, Wuhan, China.
Yingying WangDepartment of Immunology, College of Basic Medicine, 12550Chongqing Medical University, Chongqing, China.
Xuelan ZuoDepartment of Hematology, 89674Zhongnan Hospital of Wuhan University, Wuhan, China.ORCID 0000-0002-8577-347X
Wuhan University · CNChongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionClassical Philadelphia-negative myeloproliferative neoplasm (MPN) includes Essential Thrombocythemia (ET), Polycythemia Vera (PV) and Primary Myelofibrosis (PMF). The

methodsAllele specific real-time quantitative fluorescence PCR (AS-qPCR) was conducted to detect

results

conclusionsOur data revealed that combination of

Indexed as

Myeloproliferative DisordersPolycythemia VeraThrombocythemia, EssentialAllelesHumansJanus Kinase 2MutationRetrospective StudiesWT1 ProteinsJAK2 protein, humanJanus Kinase 2WT1 protein, humanWT1 ProteinsETJAK2V617MPNPMFPVWT1

Identifiers

PMID36895113
PMCPMC10009047
OpenAlexW4323812288

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.